MS Parvatiyar, AJ Brownstein… - JCI insight, 2019 - ncbi.nlm.nih.gov
In the current preclinical study, we demonstrate the therapeutic potential of sarcospan (SSPN) overexpression to alleviate cardiomyopathy associated with Duchenne muscular …
IEC Verhaart, K Putker, D van de Vijver… - PLoS …, 2019 - journals.plos.org
Limb girdle muscular dystrophy (LGMD) types 2D and 2F are caused by mutations in the genes encoding for α-and δ-sarcoglycan, respectively, leading to progressive muscle …
Background Muscular dystrophy (MD) causes a progressive cardiomyopathy characterized by diffuse fibrosis, arrhythmia, heart failure, and early death. Activation of the thromboxane …
M van Putten, C Tanganyika-de Winter… - nucleic acid …, 2019 - liebertpub.com
Duchenne muscular dystrophy is a severe, progressive muscle-wasting disease that is caused by mutations that abolish the production of functional dystrophin protein. The exon …
KS Cho, MK Neog, JY Kim, HI Yang, KS Kim - Taurine 11, 2019 - Springer
Most studies of taurine on athletic performance have been conducted at acute and high doses in rodents. These doses and duration of administration are not reasonable for normal …
RESUMO A distrofia muscular de Duchenne (DMD) é caracterizada pela falta da distrofina. Em ausência de distrofina ocorre instabilidade do sarcolema, entrada excessiva de cálcio e …
Duchenne muscular dystrophy (DMD) is the most common inherited pediatric muscle dystrophy. It is characterized by muscle degeneration, resulting in fibrosis that is a significant …
Patients of the fatal neuromuscular disorder Duchenne Muscular Dystrophy (DMD) frequently present with complex intellectual and neuropsychiatric comorbidities that are …
A Boulanger Piette - 2019 - library-archives.canada.ca
La dystrophie musculaire de Duchenne est caractérisée par une dégénérescence musculaire progressive accompagnée d'une fragilité osseuse exacerbée par la norme de …